Search Results
2017 ASCO Annual Meeting Highlights, Priority Reviews in AML and RCC, and the Giants of Cancer Care
Melanoma Highlights from ASCO 2017 - Dr. Nicolas Acquavella
ASCO 2017: Expert discussion on the latest in prostate cancer
Breast Cancer Highlights from ASCO 2017 - Dr. Gilberto Amorim
Treating Intermediate and Favorable-Risk Renal Cell Carcinoma
What's Next in Research: Findings from the 2017 ASCO GI Cancers Symposium
Dr. McDermott on Immunotherapy as a Standard of Care in RCC
VEGF TKI Therapy in the Adjuvant Setting of RCC
Dr. McDermott on Nivolumab Plus Ipilimumab in RCC
Breakthroughs in Renal Cell Carcinoma with Dr. Al Copland
Important topics at ESMO 2017
iwAL 2018 day 2 discussion: novel approaches and targeted therapies in AML
